Plasma levels of C-reactive protein: a cardiovascular risk factor indicator in overweight and obese Sudanese adults

Sahar Siddig Gamil, Khalid Hussein Bakheit, Mohammad Eltaher Adam


Background: C-reactive protein (CRP) is a member of the class of acute-phase reactants, as its levels rise
dramatically during inflammatory processes occurring in the body. This increment is due to a rise in the
plasma concentration of IL-6, which is produced predominantly by macrophages as well as adipocytes. This
study aims to test whether overweight and obesity are associated with low-grade systemic inflammation as
measured by serum C-reactive protein (CRP) level.
Methods: The study involved 20-60 years old Sudanese. Body weight and height were measured
using standardized procedures. Blood samples were drawn in plain containers; Serum specimens for the
measurement of CRP were analyzed using a high-sensitivity CPR test.
Results: The sample of the present study has included 41 males and 20 females with an age range between
18 and 52 years, the sample was divided into 3 groups according to their body mass index into 21 normal
weight (BMI=22.17±1.45 ), 20 overweight ( BMI= 27.68± 1.15 ) and 20 obese (BMI= 34.15± 3.54 ). The
normal weight group had the lowest levels of C-reactive protein (2.15 ±2.52 mg/l) and obese the highest
(3.95± 2.78 mg/l). Plasma levels of C-reactive protein showed a positive and significant correlation with
body mass index (p< 0.05).
Conclusion: This study has shown that, in Sudanese adults, a positive and significant relationship was
observed between levels of CRP and measures of obesity (BMI). In addition, a relation was found between
obesity and risk of developing cardiovascular diseases, these findings suggest a state of low-grade systemic
inflammation in overweight and obese persons. This result study extends recent observations made by
other investigators.


Plasma; levels of ;C-reactive ;protein; a cardiovascular ;risk; factor; indicator in ;overweight and obese; Sudanese ;adults

Full Text:



Bourne LT, Lambert EV, Steyn K. Where does

the black population of South Africa stand on

the nutrition transition? Public Health Nutr

; 5:157-162.

A.O. Musaiger. Overweight and obesity in the

Eastern Mediterranean Region: can we control

it? Eastern Mediterranean Health Journal


Sundquist K, Malmstrom M, Johansson SE:

Neighbourhood deprivation and incidence of

coronary heart disease: a multilevel study of 2.6

million women and men in Sweden. J Epidemiol

Community Health 2004, 58:71-77.

Kuga S, Njelekela M, Noguchi T, et al.

Prevalence of overweight and hypertension in

Tanzania: special emphasis on resting energy

expenditure and leptin. Clin Exp Pharmacol

Physiol Suppl 2002, 29: 23-26.

Department of Health. South Africa

Demographic and Health Survey 1998. Full


Pepys, MB; Hirschfield, GM.C-reactive protein:

a critical update.J Clin Invest 2003; 111:1805–

Lau DC, Dhillon B, Yan H et al.Adipokines:

molecular links between obesity and

Sahar Siddig Gamil, Khalid Hussein Bakheit, Mohammad Eltaher Adam

atheroslcerosis. Am J Physiol Heart Circ

Physiol 2004; 288: 2031–41.

Alexander J. Szalai. The biological functions

of C-reactive protein. Vascular Pharmacology

; 39:105-107

Mohamed-Ali V, Goodrick S, Rawesh A,

et al. Subcutaneous adipose tissue releases

interleukin-6, but not tumor necrosis factor-α, in

vivo. J Clin Endocrinol Metab. 1997;82:4196-

Caro JF1, Sinha MK, Kolaczynski JW, Zhang

PL, Considine RV. Leptin: the tale of an obesity

gene.Diabetes1996; 45:1455–1462.

P. Calabro,, D.W. Chang,, J.T. Willerson, and

E. T.H. Yeh,. Release of C-Reactive Protein

in Response to Inflammatory Cytokines

by Human Adipocytes: Linking Obesity to

Vascular Inflammation,J Am Coll Cardiol

; 46:1112-1113,

Ridker PM, Cushman M, Stampfer MJ, Tracy

RP, Hennekens CH. Inflammation, aspirin, and

the risk of cardiovascular disease in apparently

healthy men. N Engl J Med 1997; 336: 973–

Ridker PM, Hennekens CH, Buring JE, Rifai

N. C-reactive protein and other markers of

inflammation in the prediction of cardiovascular

disease in women. N Engl J Med 2000; 342:


Ridker PM, Cushman M, Stampfer MJ, Tracy

RP, Hennekens CH. Plasma concentration

of C-reactive protein and risk of developing

peripheral vascular disease. Circulation 1998;

: 425–428.

Koenig W, Sund M, Frohlich M, et al.

C-reactive protein, a sensitive marker of

inflammation, predicts future risk of coronary

heart disease in initially healthy middle-aged

men: results from the MONICA (Monitoring

Trends and Determinants in Cardiovascular

Disease) Augsburg Cohort Study, 1984–1992.

Circulation 1999; 99:237–242.

Danesh J, Collins R, Appleby P, Peto R.

Association of fibrinogen, C-reactive protein,

albumin, or leukocyte count with coronary

heart disease: meta-analyses of prospective

studies. JAMA 1998; 279: 1477–1482.

Griselli M, Herbert J, Hutchinson WL, et

al. C-reactive protein and complement are

important mediators of tissue damage in acute

myocardial infarction. J Exp Med 1999; 190:


WHO. Obesity: preventing and managing

the global epidemic. Report of a WHO

Consultation. WHO Technical Report Series

Geneva: World Health Organization, 2000.

Visser M, Bouter LM, McQuillan GM, Wener

MH, Harris TB. Elevated C-Reactive Protein

Levels in Overweight and Obese Adults. JAMA.


Elisabeth Hak, Coen D. A. Stehouwer,

Michiel L. Bots, Kees H. Polderman, Casper

G. Schalkwijk, Iris C. D. Westendorp, Albert

Hofman, and Jacqueline C. M. Witteman.

Associations of C-Reactive Protein With

Measures of Obesity, Insulin Resistance, and

Subclinical Atherosclerosis in Healthy, Middle-

Aged Women.Arterioscler Thromb Vasc Biol.


Forouhi NG, Sattar N, McKeigue PM. Relation

of C-reactive protein to body fat distribution

and features of the metabolic syndrome in

Europeans and South Asians. Int J Obes Relat

Metab Disord. 2001;25: 1327-1331.

Hotamisligil GS, Shargill NS, Spiegelman BM.

Adipose expression of tumor necrosis factor-α:

direct role in obesity-linked insulin resistance.

Science 1993; 259:87–91.

Khera A, McGuire DK, Murphy SA, et al. Race

and Gender Differences in C-Reactive Protein

Levels. J Am Coll Cardio 2005 ;46:464-469


  • There are currently no refbacks.

ISSN: 1858-5345